Objective: To investigate the difference of biological characteristics between the praziquantel-resistant and -susceptible isolates of in intermediate host snails.
Methods: Mice were infected with cercariae of praziquantel-resistant and -susceptible isolates of , and the parasite eggs were collected 37 days post-infection to hatch miracidium. Then, the snails were infected with the miracidium of each parasite isolate. The snail infection, survival rate of infected snails, prepatent period of cercariae, and the total number of cercariae shed from each infected snail were observed and compared between the praziquantel-resistant and -susceptible isolates of .
Results: If each snail was exposed to a single miracidium, there were significant differences between the praziquantel-resistant and -susceptible Jiangsu isolates in the snail infection (8.99% vs. 19.74%; = 3.948, = 0.047) and the number of cercaria released from a single snail (1 460.2 vs. 1 039.3; = 2.507, = 0.02), and there were significant differences between the praziquantel-susceptible and -resistant Hunan isolates in the snail infection (10.00% vs. 21.52%; = 3.980, = 0.046) and the number of cercaria released from a single snail (1 319.4 vs. 1 003.5; = 2.566, = 0.017). However, there were no significant differences between the praziquantel-resistant and -susceptible isolates of in the prepatent period of cercariae and the survival rate of infected snails ( > 0.05).
Conclusions: The praziquantel-resistant isolate of has a higher susceptibility to but less cercaria released from each infected snail than the susceptible isolate.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.16250/j.32.1374.2017101 | DOI Listing |
bioRxiv
November 2024
Department of Pathobiological Sciences, University of Wisconsin - Madison, Madison, WI, USA.
There are limited control measures for the disease schistosomiasis, despite the fact that infection with parasitic blood flukes affects hundreds of millions of people worldwide. The current treatment, praziquantel, has been in use since the 1980's and there is a concern that drug resistance may emerge with continued monotherapy. Given the need for additional antischistosomal drugs, we have re-visited an old lead, meclonazepam.
View Article and Find Full Text PDFEvol Appl
April 2018
Institute for Biodiversity, Animal Health and Comparative Medicine University of Glasgow Glasgow UK.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi
December 2017
Key Laboratory of National Health and Family Planning Commission on Technology for Parasitic Disease Prevention and Control, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Public Health Research Center of Jiangnan University, Wuxi 214064, China.
Objective: To investigate the biological characteristics of the praziquantel-resistant isolate of in mice, so as to explore the pathogenicity to definitive hosts and transmission intensity of the praziquantel-resistant isolate of .
Methods: Mice were infected with the cercariae released from two praziquantel-resistant isolates and two praziquantel-susceptible isolates of . The mouse- snail-mouse cycle was established and maintained in the laboratory.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi
December 2017
Key Laboratory of National Health and Family Planning Commission on Technology for Parasitic Disease Prevention and Control, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Public Health Research Center of Jiangnan University, Wuxi 214064, China.
Objective: To investigate the difference of biological characteristics between the praziquantel-resistant and -susceptible isolates of in intermediate host snails.
Methods: Mice were infected with cercariae of praziquantel-resistant and -susceptible isolates of , and the parasite eggs were collected 37 days post-infection to hatch miracidium. Then, the snails were infected with the miracidium of each parasite isolate.
Infect Dis Poverty
February 2018
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, Ministry of Health, WHO Collaborating Centre for Tropical Diseases, Shanghai, 200025, People's Republic of China.
Background: Chemotherapy for schistosomiasis has been around for 100 years. During the past century, great efforts have been made to develop new antischistosomal drugs from antimonials to nonantimonials, and some of these have been used extensively in clinical treatment. With the exception of a few drugs, such as oxamniquine and metrifonate, most of the antischistosomals developed in the pre-praziquantel period have variable limitations with respect to safety and efficacy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!